Thursday , August 11 2022

Novavida supports immune cancer research.


Bangkok – November 12 – Nova Vida

Novavida Integrative Medical Center, 100,000 Baht donation to Cancer Treatment Center Ministry of Medicine Khun Thaweesak Vorakornvichit, Khun Anant Taveesangsiri, Khun Soras Vithitakornvijit and Khun Trisit Pisitkul, Head of Center for Systemic Biology Chulalongkorn University as a donor Chulalongkorn University Chulalongkorn Memorial Hospital

CU Cancer Immunotherapy Fund, Center of Excellence in Immunotherapy, Cancer Data Dr. Trisit Pitsutkul of Longkorn University Medical School has described his research data as a hope for cancer patients.

"We are developing antibodies to cancer, how to release leukocyte function, and the Nobel Prize winner Tasuku Honjo leads to the development of a treatment for PD-1 protein cancer, in which some cancer cells bind to PD-1 and leukocytes become cancerous A protein that blocks lymphocytes as "braking" that prevents it from destroying it.

The antibody developed here is Immune Checkpoint Inhibitor which interrupts the process of lifting the brakes and deciphering the function of the white blood cells. Cancer cells can be destroyed. We all have a natural process that effectively detects and destroys cancer cells. Only some processes are blocked. This antibody is the hope of future cancer treatment in Thailand. The same applies to imported medicines and current high prices.

Patients who respond to drugs. There is a very good healing effect. It is more effective when combined with other immunotherapy. Immunotherapy Excellence Center This drug has been developed as an alternative to the Thai people. There are currently studies to predict the response of antibodies. DNA test. center. Genetic analysis has been developed to predict drug analysis. "

Interested persons can donate at the Chulalongkorn Memorial Cancer Center. Savings Account Number 408-004443-4 Siam Commercial Bank Email: [email protected], Facebook Fan Page CU Cancer Immunotherapy Fund. Receipts can be deducted twice.

Source link